Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Consumer Products Business Steers Toward Acquisitions For Growth

Executive Summary

Sales of Tylenol, Motrin and other analgesics increased more than 13% during the firm's latest quarter as total US OTC sales reached $389m. Sales of the Listerine line grew 7% to drive domestic oral care product sales up 8.2% to $159m.


Related Content

J&J Invests In Consumer Business For Long Haul, Not Quick Sale
J&J Affirms M&A Strategy For Consumer Biz With Vogue International Buy
'Virtuous Circle' Cycles J&J Consumer From Consent Decree To Growth
J&J Heralds Year Of 'Good Momentum' For Consumer Health Business


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts